Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing

详细信息    查看全文

• 作者：Milan Radovich (1)
  Susan E. Clare (1)
  Rutuja Atale (1)
  Ivanesa Pardo (1)
  Bradley A. Hancock (1)
  Jeffrey P. Solzak (1)
  Nawal Kassem (2)
  Theresa Mathieson (3)
  Anna Maria V. Storniolo (2) (3)
  Connie Rufenbarger (3)
  Heather A. Lillemoe (1)
  Rachel J. Blosser (1)
  Mi Ran Choi (1)
  Candice A. Sauder (1)
  Diane Doxey (1)
  Jill E. Henry (3)
  Eric E. Hilligoss (6)
  Onur Sakarya (6)
  Fiona C. Hyland (6)
  Matthew Hickenbotham (6)
  Jin Zhu (7)
  Jarret Glasscock (7)
  Sunil Badve (4)
  Mircea Ivan (2)
  Yunlong Liu (5)
  George W. Sledge (8)
  Bryan P. Schneider (2) (5)
  
• 关键词：Triple ; negative breast cancer ; RNA ; seq ; TCGA ; Normal breast ; Adjacent normal ; Ductal epithelium
• 刊名：Breast Cancer Research and Treatment
• 出版年：2014
• 出版时间：January 2014
• 年：2014
• 卷：143
• 期：1
• 页码：57-68
• 全文大小：963 KB
• 作者单位：Milan Radovich (1)
  Susan E. Clare (1)
  Rutuja Atale (1)
  Ivanesa Pardo (1)
  Bradley A. Hancock (1)
  Jeffrey P. Solzak (1)
  Nawal Kassem (2)
  Theresa Mathieson (3)
  Anna Maria V. Storniolo (2) (3)
  Connie Rufenbarger (3)
  Heather A. Lillemoe (1)
  Rachel J. Blosser (1)
  Mi Ran Choi (1)
  Candice A. Sauder (1)
  Diane Doxey (1)
  Jill E. Henry (3)
  Eric E. Hilligoss (6)
  Onur Sakarya (6)
  Fiona C. Hyland (6)
  Matthew Hickenbotham (6)
  Jin Zhu (7)
  Jarret Glasscock (7)
  Sunil Badve (4)
  Mircea Ivan (2)
  Yunlong Liu (5)
  George W. Sledge (8)
  Bryan P. Schneider (2) (5)
  
  1. Division of General Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA
  2. Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
  3. Susan G. Komen for the Cure Tissue Bank, Indianapolis, IN, USA
  6. Life Technologies Corporation, South San Francisco, CA, USA
  7. Cofactor Genomics, LLC, St. Louis, MO, USA
  4. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
  5. Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
  8. Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
  
• ISSN：1573-7217

文摘

Triple-negative breast cancers (TNBCs) are a heterogeneous set of tumors defined by an absence of actionable therapeutic targets (ER, PR, and HER-2). Microdissected normal ductal epithelium from healthy volunteers represents a novel comparator to reveal insights into TNBC heterogeneity and to inform drug development. Using RNA-sequencing data from our institution and The Cancer Genome Atlas (TCGA) we compared the transcriptomes of 94 TNBCs, 20 microdissected normal breast tissues from healthy volunteers from the Susan G. Komen for the Cure Tissue Bank, and 10 histologically normal tissues adjacent to tumor. Pathway analysis comparing TNBCs to optimized normal controls of microdissected normal epithelium versus classic controls composed of adjacent normal tissue revealed distinct molecular signatures. Differential gene expression of TNBC compared with normal comparators demonstrated important findings for TNBC-specific clinical trials testing targeted agents; lack of over-expression for negative studies and over-expression in studies with drug activity. Next, by comparing each individual TNBC to the set of microdissected normals, we demonstrate that TNBC heterogeneity is attributable to transcriptional chaos, is associated with non-silent DNA mutational load, and explains transcriptional heterogeneity in addition to known molecular subtypes. Finally, chaos analysis identified 146 core genes dysregulated in >90?% of TNBCs revealing an over-expressed central network. In conclusion, use of microdissected normal ductal epithelium from healthy volunteers enables an optimized approach for studying TNBC and uncovers biological heterogeneity mediated by transcriptional chaos.